Rs 656 Dividend: Highest-Ever Dividend Including Special Dividend Announced by Healthcare Company; Check Record Date

The Indian equity markets opened lower on Tuesday, with the benchmark Nifty 50 index declining 0.85 per cent to 23,613.80 in early trade. Despite weakness in the broader market, select pharmaceutical stocks remained in focus. In this segment, Abbott India witnessed selling pressure after the company announced its Q4FY26 and FY26 financial results along with Dividend declaration. On Tuesday, Abbott India share price declined 2 per cent to Rs 27,240.00.

Dividend Announcement

The Board of Directors recommended a final dividend of Rs 525 per equity share and a special dividend of Rs 131 per equity share of face value Rs 10 each for FY26, taking the total dividend payout for the financial year to Rs 656 per equity share, subject to shareholder approval. The company fixed July 24, 2026 as the record date for determining shareholder eligibility.

Abbott India Q4FY26 Results

Abbott India reported revenue from operations of Rs 1,709.51 crore in Q4FY26 as against Rs 1,604.59 crore reported in Q4FY25, registering a growth of 6.5 per cent YoY. Total income for the quarter stood at Rs 1,785.10 crore compared to Rs 1,680.61 crore in the corresponding quarter previous year.

Profit before Tax came in at Rs 531.23 crore during Q4FY26 as against Rs 482.71 crore reported in Q4FY25, reflecting a growth of 10 per cent YoY. Profit after tax stood at Rs 394.93 crore in Q4FY26 compared to Rs 367.04 crore reported in the corresponding quarter last year, registering a growth of 7.6 per cent YoY. Earnings per share for the quarter stood at Rs 185.85 compared to Rs 172.72 reported in Q4FY25.

Abbott India FY26 Annual Performance

For the financial year ended March 31, 2026, Abbott India reported revenue from operations of Rs 6,929.05 crore as against Rs 6,409.15 crore reported in FY25, registering a growth of 8.1 per cent YoY. Total income for FY26 stood at Rs 7,217.19 crore compared to Rs 6,684.73 crore in FY25.

Profit before tax came in at Rs 2,079.27 crore during FY26 as against Rs 1,886.95 crore reported in FY25, reflecting a growth of 10.2 per cent YoY. Profit after tax stood at Rs 1,552.02 crore in FY26 compared to Rs 1,414.44 crore reported in the previous financial year, registering a growth of 9.7 per cent YoY. Earnings per share for FY26 stood at Rs 730.36 compared to Rs 665.62 in FY25.

Abbott India Dividend History Over The Last Five Years

Other Developments

During FY26, Abbott India recognised an incremental employee benefit cost of Rs 18.10 crore following assesSMEnt of implications related to the new Labour Codes notified by the Government of India.

The company also informed exchanges that the Board approved appointment of M/s Kishore Bhatia & Associates as Cost Auditors for FY27, subject to shareholder ratification at the upcoming AGM.

About Abbott India

Abbott India Limited is engaged in the pharmaceuticals business and operates across multiple therapeutic segments including gastroenterology, women’s health, metabolic disorders, central nervous system and vaccines. The company markets branded generic pharmaceutical products and healthcare solutions in India and is part of global healthcare major Abbott Laboratories.

Share your views on Abbott India’s Q4FY26 performance and dividend announcement in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.